Design Therapeutics (DSGN) Q2 2025 Earnings

7MayConfirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-0.31
-0.28
-0.24
-0.21

Details

Expected EPS
-0.28
Actual EPS
-0.31
Surprise EPS
-0.03
Surprise Percent
+10.71%

Description

Design Therapeutics (DSGN) has reported earnings of -0.31 per share for Q2 2025.

0 Comments

Share your thoughts